BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the Latest Evidence
- PMID: 28711165
- DOI: 10.1016/j.ad.2016.12.025
BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the Latest Evidence
Abstract
The identification of B-Raf proto-oncongene (BRAF) mutation and the emergence of targeted therapy marked a turning point in the treatment of melanoma. The study of mutation status concordance between primary tumors and metastases in this cancer has major treatment implications as it facilitates the selection of candidates for targeted therapy. This review analyzes the evidence on the level of mutation status concordance between primary tumors and different types of metastases in cutaneous melanoma and provides an overview of the advantages and disadvantages of the various methods used to detect BRAF mutations.
Keywords: BRAF; Concordance; Concordancia; Heterogeneidad intratumoral; Intratumoral heterogeneity; Melanoma; Metastasis; Metástasis.
Copyright © 2017 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.Exp Mol Pathol. 2014 Dec;97(3):315-20. doi: 10.1016/j.yexmp.2014.09.008. Epub 2014 Sep 16. Exp Mol Pathol. 2014. PMID: 25236573
-
[Cellular and molecular mechanisms of carcinogenic side effects and resistance to BRAF inhibitors in metastatic melanoma with BRAFV600 mutation: state of the knowledge].Ann Pathol. 2013 Dec;33(6):375-85. doi: 10.1016/j.annpat.2013.09.003. Epub 2013 Oct 31. Ann Pathol. 2013. PMID: 24331719 Review. French.
-
Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8. Melanoma Res. 2012. PMID: 22456166
-
[Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].Magy Onkol. 2013 Jun;57(2):96-9. Epub 2013 May 20. Magy Onkol. 2013. PMID: 23795354 Hungarian.
-
Mutation stability in primary and metastatic melanoma: what we know and what we don't.Histol Histopathol. 2015 Jul;30(7):763-70. doi: 10.14670/HH-11-584. Epub 2015 Jan 13. Histol Histopathol. 2015. PMID: 25585249 Review.
Cited by
-
Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective.Front Oncol. 2023 Mar 14;13:1032300. doi: 10.3389/fonc.2023.1032300. eCollection 2023. Front Oncol. 2023. PMID: 36998456 Free PMC article. Review.
-
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach.J Transl Med. 2019 Aug 28;17(1):289. doi: 10.1186/s12967-019-2039-4. J Transl Med. 2019. PMID: 31455347 Free PMC article.
-
Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling.Front Chem. 2018 Sep 28;6:434. doi: 10.3389/fchem.2018.00434. eCollection 2018. Front Chem. 2018. PMID: 30324102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
